Fingerprint
Dive into the research topics of 'CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial
W. He, M. Eriksson, E. Eliasson, F. Grassmann, M. Bäcklund, M. Gabrielson, M. Hammarström, S. Margolin, L. Thorén, Y. Wengström, S. Borgquist, P. Hall*, K. Czene
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
12
Citations
(Scopus)
1
Downloads
(Pure)